These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 10440603

  • 1. Effect of 7-day therapy with different doses of the proton pump inhibitor lansoprazole on the intragastric pH in healthy human subjects.
    Harder H, Teyssen S, Stephan F, Pfützer R, Kiel G, Fuchs W, Singer MV.
    Scand J Gastroenterol; 1999 Jun; 34(6):551-61. PubMed ID: 10440603
    [Abstract] [Full Text] [Related]

  • 2. Comparison of lansoprazole with omeprazole on 24-hour intragastric pH, acid secretion and serum gastrin in healthy volunteers.
    Bruley des Varannes S, Levy P, Lartigue S, Dellatolas F, Lemaire M, Galmiche JP.
    Aliment Pharmacol Ther; 1994 Jun; 8(3):309-14. PubMed ID: 7918926
    [Abstract] [Full Text] [Related]

  • 3. Effect of four lansoprazole dose levels and one dosage regimen of omeprazole on 24-hour intragastric pH in healthy subjects.
    Timmer W, Ripke H, Kleist P, Ehrlich A, Wieckhorst G, Lücker PW, Fuder H.
    Methods Find Exp Clin Pharmacol; 1995 Sep; 17(7):489-95. PubMed ID: 8577212
    [Abstract] [Full Text] [Related]

  • 4. Control of intragastric pH with omeprazole 20 mg, omeprazole 40 mg and lansoprazole 30 mg.
    Katz PO, Xue S, Castell DO.
    Aliment Pharmacol Ther; 2001 May; 15(5):647-52. PubMed ID: 11328258
    [Abstract] [Full Text] [Related]

  • 5. A placebo-controlled trial to assess the effects of 8 days of dosing with rabeprazole versus omeprazole on 24-h intragastric acidity and plasma gastrin concentrations in young healthy male subjects.
    Williams MP, Sercombe J, Hamilton MI, Pounder RE.
    Aliment Pharmacol Ther; 1998 Nov; 12(11):1079-89. PubMed ID: 9845397
    [Abstract] [Full Text] [Related]

  • 6. Gastric acidity and acid breakthrough with twice-daily omeprazole or lansoprazole.
    Katz PO, Hatlebakk JG, Castell DO.
    Aliment Pharmacol Ther; 2000 Jun; 14(6):709-14. PubMed ID: 10848653
    [Abstract] [Full Text] [Related]

  • 7. Dose-response relationship of lansoprazole to gastric acid antisecretory effects.
    Blum RA, Hunt RH, Kidd SL, Shi H, Jennings DE, Greski-Rose PA.
    Aliment Pharmacol Ther; 1998 Apr; 12(4):321-7. PubMed ID: 9690720
    [Abstract] [Full Text] [Related]

  • 8. Eradication of Helicobacter pylori increases nocturnal intragastric acidity during dosing with rabeprazole, omeprazole, lansoprazole and placebo.
    Williams MP, Usselmann B, Chilton A, Sercombe J, Nwokolo CU, Pounder RE.
    Aliment Pharmacol Ther; 2003 Mar 15; 17(6):775-83. PubMed ID: 12641499
    [Abstract] [Full Text] [Related]

  • 9. Proton pump inhibitors: better acid suppression when taken before a meal than without a meal.
    Hatlebakk JG, Katz PO, Camacho-Lobato L, Castell DO.
    Aliment Pharmacol Ther; 2000 Oct 15; 14(10):1267-72. PubMed ID: 11012470
    [Abstract] [Full Text] [Related]

  • 10. Influence of lansoprazole on intragastric 24-hour pH, meal-stimulated gastric acid secretion, and concentrations of gastrointestinal hormones and enzymes in serum and gastric juice in healthy volunteers.
    Brunner G, Hell M, Hengels KJ, Hennig U, Fuchs W.
    Digestion; 1995 Oct 15; 56(2):137-44. PubMed ID: 7750667
    [Abstract] [Full Text] [Related]

  • 11. Acid-suppressive effects of rabeprazole, omeprazole, and lansoprazole at reduced and standard doses: a crossover comparative study in homozygous extensive metabolizers of cytochrome P450 2C19.
    Shimatani T, Inoue M, Kuroiwa T, Xu J, Mieno H, Nakamura M, Tazuma S.
    Clin Pharmacol Ther; 2006 Jan 15; 79(1):144-52. PubMed ID: 16413249
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the effect of lansoprazole and omeprazole on intragastric acidity and gastroesophageal reflux in patients with gastroesophageal reflux disease.
    Janczewska I, Sagar M, Sjöstedt S, Hammarlund B, Iwarzon M, Seensalu R.
    Scand J Gastroenterol; 1998 Dec 15; 33(12):1239-43. PubMed ID: 9930385
    [Abstract] [Full Text] [Related]

  • 13. Acid-suppressive efficacy of a reduced dosage of rabeprazole: comparison of 10 mg twice daily rabeprazole with 20 mg twice daily rabeprazole, 30 mg twice daily lansoprazole, and 20 mg twice daily omeprazole by 24-hr intragastric pH-metry.
    Shimatani T, Inoue M, Kuroiwa T, Xu J, Tazuma S, Horikawa Y, Nakamura M.
    Dig Dis Sci; 2005 Jul 15; 50(7):1202-6. PubMed ID: 16047460
    [Abstract] [Full Text] [Related]

  • 14. Acid-inhibitory effects of omeprazole and lansoprazole in Helicobacter pylori-negative healthy subjects.
    Geus WP, Mulder PG, Nicolai JJ, Van den Boomgaard DM, Lamers CB.
    Aliment Pharmacol Ther; 1998 Apr 15; 12(4):329-35. PubMed ID: 9690721
    [Abstract] [Full Text] [Related]

  • 15. Morning versus evening dosing of lansoprazole 30 mg daily on twenty-four-hour intragastric acidity in healthy subjects.
    Fraser AG, Sawyerr AM, Hudson M, Smith MS, Pounder RE.
    Aliment Pharmacol Ther; 1996 Aug 15; 10(4):523-7. PubMed ID: 8853755
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Acid inhibition on the first day of dosing: comparison of four proton pump inhibitors.
    Pantoflickova D, Dorta G, Ravic M, Jornod P, Blum AL.
    Aliment Pharmacol Ther; 2003 Jun 15; 17(12):1507-14. PubMed ID: 12823153
    [Abstract] [Full Text] [Related]

  • 18. Effects of omeprazole and lansoprazole on 24-hour intragastric pH in Helicobacter pylori-positive volunteers.
    Verdú EF, Fraser R, Armstrong D, Blum AL.
    Scand J Gastroenterol; 1994 Dec 15; 29(12):1065-9. PubMed ID: 7886393
    [Abstract] [Full Text] [Related]

  • 19. The effects of oral doses of lansoprazole and omeprazole on gastric pH.
    Tolman KG, Sanders SW, Buchi KN, Karol MD, Jennings DE, Ringham GL.
    J Clin Gastroenterol; 1997 Mar 15; 24(2):65-70. PubMed ID: 9077718
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.